PLRX - Pliant Therapeutics, Inc.

Name: Pliant Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Bernard Coulie	505.6K	$435.2K	-
CFO	Keith Lamont Cummings	297.2K	$255.8K	-
Other	Lily Cheung	44.8K	$38.6K	-
COO	Minnie Kuo	37.8K	$32.5K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 4, 2023	Hans Hull79	Chief Business Officer	Sale+OE10b5-1	34,919	$20.01	$698,580.50	-15.2%	-25.4%	-31.2%
Jul 20, 2023	Mike Ouimette81	General Counsel & Corp. Sec'y	Sell10b5-1	4,755	$17.55	$83,450.25	-7.3%	-22.6%	-29.4%
Jul 17, 2023	Mike Ouimette81	General Counsel & Corp. Sec'y	Sell10b5-1	12,778	$18.01	$230,120.28	-16.4%	-13.7%	-24.3%
Jul 17, 2023	Eric Lefebvre82	Chief Medical Officer	Sell10b5-1	22,321	$18.01	$401,981.12	-11.8%	-13.7%	-24.3%
Jul 17, 2023	Hans Hull79	Chief Business Officer	Sell10b5-1	17,937	$18.01	$323,029.23	-7.6%	-13.7%	-24.3%
Jul 17, 2023	Keith Lamont Cummings75	Chief Financial Officer	Sell10b5-1	19,771	$18.01	$356,057.92	-8.8%	-13.7%	-24.3%
Jul 17, 2023	Bernard Coulie80	President and CEO	Sell10b5-1	70,150	$18.01	$1,263,338.37	-17.0%	-13.7%	-24.3%
Apr 3, 2023	Mike Ouimette81	General Counsel & Corp. Sec'y	Sell10b5-1	7,751	$26.62	$206,329.08	-13.2%	-32.0%	-44.6%
Mar 30, 2023	Eric Lefebvre82	Chief Medical Officer	Sell10b5-1	11,245	$26.52	$298,227.52	-7.2%	-28.3%	-43.9%
Mar 30, 2023	Hans Hull79	Chief Business Officer	Sell10b5-1	9,036	$26.52	$239,642.85	-4.3%	-28.3%	-43.9%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC